FDA approves Takeda's orexin drug for narcolepsy type 1
read at Endpoints ↗ApprovalPositive
Takeda has received FDA approval for its orexin agonist intended to treat narcolepsy type 1.
The decision ends a closely watched commercial race to bring an orexin-based therapy to market.
With approval secured, the drug can now be launched, offering a new option for patients living with the disorder.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “FDA approves Takeda's orexin drug for narcolepsy”
read at Endpoints ↗85 words · retrieved Aug 5
comments(0)
5-min edit window · permanent after that